cjc dac and ipamorelin CJC-1295 + Ipamorelin: Benefits, Differences, When to Combine – Revolution Health & Wellness CJC-1295 (No DAC) + Ipamorelin

GHRP-6 also binds to the ectodomain of CD36, a receptor involved in fatty acid uptake, angiogenesis, and immune function

Tesamorelin is clinically studied for reducing visceral abdominal fat, and results appear after 4-8 weeks of consistent dosing

The 13 mg blend (10 mg Tesamorelin + 3 mg Ipamorelin) is intended as a comparative pharmacology research blend for investigators studying paired GHRH and GHS-R pathway signaling in preclinical models of body composition, growth hormone dynamics, and metabolic endpoints

Tetramers are limited by the need to utilize predicted binding peptides based on prior hypotheses, and the restriction to specific HLAs